Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Department of Medicine, Weill Cornell Medical College, New York, NY, USA.
Prostate Cancer Prostatic Dis. 2017 Dec;20(4):418-423. doi: 10.1038/pcan.2017.31. Epub 2017 Jun 27.
Obesity, a cause of subclinical inflammation, is associated with increased risk of high-grade prostate cancer (PC) and poor outcomes. Whether inflammation occurs in periprostatic white adipose tissue (WAT), and contributes to the negative impact of obesity on PC aggressiveness, is unknown.
In a single-center, cross-sectional design, men with newly diagnosed PC undergoing radical prostatectomy were eligible for study participation. The primary objective was to examine the prevalence of periprostatic WAT inflammation defined by the presence of crown-like structures (CLS-P) as detected by CD68 immunohistochemistry. Secondary objectives were to explore the clinical and systemic correlates of periprostatic WAT inflammation. Tumor characteristics and host factors including BMI, adipocyte diameter, and circulating levels of lipids, adipokines, and other metabolic factors were measured. Wilcoxon rank-sum, Chi-square, or Fisher's exact tests, and generalized linear regression were used to examine the association between WAT inflammation and tumor and host characteristics.
Periprostatic fat was collected from 169 men (median age 62 years; median BMI 28.3). Periprostatic WAT inflammation was identified in 49.7% of patients and associated with higher BMI (P=0.02), larger adipocyte size (P=0.004) and Gleason grade groups IV/V tumors (P=0.02). The relationship between WAT inflammation and high Gleason grade remained significant after adjusting for BMI (P=0.04). WAT inflammation correlated with higher circulating levels of insulin, triglycerides, and leptin/adiponectin ratio, and lower high density lipoprotein cholesterol, compared to those without WAT inflammation (P's <0.05).
Periprostatic WAT inflammation is common in this cohort of men with PC and is associated with high-grade PC.
肥胖是亚临床炎症的一个原因,与高级别前列腺癌(PC)风险增加和不良预后相关。围前列腺白色脂肪组织(WAT)是否存在炎症,以及炎症是否会对肥胖对 PC 侵袭性的负面影响产生影响,目前尚不清楚。
在一项单中心、横断面设计中,接受根治性前列腺切除术的新诊断为 PC 的男性有资格参与研究。主要目的是通过 CD68 免疫组织化学检测,检查围前列腺 WAT 炎症的患病率,定义为存在冠状结构(CLS-P)。次要目的是探索围前列腺 WAT 炎症的临床和系统相关性。测量肿瘤特征和宿主因素,包括 BMI、脂肪细胞直径以及循环水平的脂质、脂肪因子和其他代谢因子。Wilcoxon 秩和检验、卡方检验或 Fisher 精确检验和广义线性回归用于检验 WAT 炎症与肿瘤和宿主特征之间的关联。
从 169 名男性(中位年龄 62 岁;中位 BMI 28.3)中收集了围前列腺脂肪。49.7%的患者存在围前列腺 WAT 炎症,与更高的 BMI(P=0.02)、更大的脂肪细胞大小(P=0.004)和 Gleason 分级组 IV/V 肿瘤(P=0.02)相关。在调整 BMI 后,WAT 炎症与高 Gleason 分级之间的关系仍然显著(P=0.04)。与没有 WAT 炎症的患者相比,WAT 炎症与更高的循环胰岛素、甘油三酯和瘦素/脂联素比值相关,与更低的高密度脂蛋白胆固醇相关(P 值<0.05)。
在这组患有 PC 的男性中,围前列腺 WAT 炎症很常见,与高级别 PC 相关。